Results 231 to 240 of about 1,183,167 (309)

Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension. [PDF]

Front Med (Lausanne)
Li Y, Zhu B, Shi K, Lu Y, Zeng X, Li Y, Zhang Q, Feng Y, Wang X.   +8 more
europepmc   +1 more source

Intestinal epithelial injury and inflammation after physical work in temperate and hot environments in older men with hypertension or type 2 diabetes

Experimental Physiology, EarlyView.
Abstract We tested whether older adults with well‐controlled type 2 diabetes or hypertension, compared with age‐matched adults without chronic disease, exhibit greater intestinal damage, microbial translocation and inflammation during exertional heat stress.
Ben J. Lee, Tessa R. Flood, Sophie L. Russell, James J. McCormick, Kelli E. King, Naoto Fujii, Tatsuro Amano, Sean Notley, Glen P. Kenny   +8 more
wiley   +1 more source

Rethinking portal hypertension in hepatocellular carcinoma resection: a gradient of risk beyond black and white. [PDF]

Hepatobiliary Surg Nutr
Pereyra D, Starlinger P.
europepmc   +1 more source

Portal hypertension in children

Current Problems in Surgery, 1966
openaire   +4 more sources

Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer‐related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer‐reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients
Dimitrios Moris, Alessandro Martinino, Sarah Schiltz, Peter J. Allen, Andrew Barbas, Debra Sudan, Lindsay King, Carl Berg, Charles Kim, Mustafa Bashir, Manisha Palta, Michael A. Morse, Michael E. Lidsky   +12 more
wiley   +1 more source

Case Report: Partial Splenic Artery Embolization for the Treatment of Painful Splenomegaly Secondary to Noncirrhotic Portal Hypertension. [PDF]

Case Reports Hepatol
Kratzer L, Waters M, Parkes S, Cheung N, Shackel N.   +4 more
europepmc   +1 more source

Noninvasive prediction of clinically significant portal hypertension in metabolic dysfunction-associated steatotic liver disease compared to other chronic liver diseases. [PDF]

World J Hepatol
Masood M, Thandassery RB.
europepmc   +1 more source

Genetic association analysis between LDL-c lowering drugs and portal hypertension using Mendelian randomization analysis. [PDF]

Sci Rep
Xiao QA, Li XL, Qin L, Zhang XL.
europepmc   +1 more source

A novel noninvasive assessment of portal pressure from computational biofluid mechanics in patients with portal hypertension. [PDF]

Trials
Zheng L, Wu G, Lin J, Li H, Zhang C, Zhao Z, Chen M, Wu Z, Luo G, Fan Q, Qi X, Huo H, Sun L, Luo M.   +13 more
europepmc   +1 more source